DLK1 is a GATA1s-driven dependency and therapeutic target in Down syndrome-associated myeloid leukemia.
- DOI
- 10.1182/bloodadvances.2025018830
- Published
- 2026 Jun 23
- Container
- Blood advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2025018830,
title = {DLK1 is a GATA1s-driven dependency and therapeutic target in Down syndrome-associated myeloid leukemia.},
author = {Verboon LJ and Barwe SP and Tavenner M and Faust JR and Issa H and Gonçalves-Dias J and Schuschel K and Bhayadia R and van Berkel PH and Sebastian A and Ries RE and Paczesny S and Meshinchi S and Hitzler J and Pikman Y and Kolb EA and Heckl D and Klusmann JH and Gopalakrishnapillai A},
year = {2026},
journal = {Blood advances},
doi = {10.1182/bloodadvances.2025018830},
url = {https://doi.org/10.1182/bloodadvances.2025018830}
}RIS
TY - JOUR TI - DLK1 is a GATA1s-driven dependency and therapeutic target in Down syndrome-associated myeloid leukemia. AU - Verboon LJ AU - Barwe SP AU - Tavenner M AU - Faust JR AU - Issa H AU - Gonçalves-Dias J AU - Schuschel K AU - Bhayadia R AU - van Berkel PH AU - Sebastian A AU - Ries RE AU - Paczesny S AU - Meshinchi S AU - Hitzler J AU - Pikman Y AU - Kolb EA AU - Heckl D AU - Klusmann JH AU - Gopalakrishnapillai A PY - 2026 JO - Blood advances DO - 10.1182/bloodadvances.2025018830 UR - https://doi.org/10.1182/bloodadvances.2025018830 ER -
APA
LJ, V., SP, B., M, T., JR, F., H, I., J, G., K, S., R, B., PH, V. B., A, S., RE, R., S, P., S, M., J, H., Y, P., EA, K., D, H., JH, K., & A, G. (2026). DLK1 is a GATA1s-driven dependency and therapeutic target in Down syndrome-associated myeloid leukemia.. Blood advances. https://doi.org/10.1182/bloodadvances.2025018830
Source records
- pubmed · retrieved 2026-09-26T08:21:01.427Z